Genetic Variation and Hematology: Single-Nucleotide Polymorphisms, Haplotypes, and Complex Disease

Seminars in Hematology

Volumn 40, Issue 4, 2003, Pages 321-328

  Chanock, Stephen ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; AZATHIOPRINE; MERCAPTOPURINE; TIOGUANINE;

BLOOD TOXICITY; DRUG TARGETING; ENVIRONMENTAL FACTOR; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HEMATOLOGIC DISEASE; HEMATOLOGY; HUMAN; HUMAN GENOME; LEUKEMIA; PHARMACOGENOMICS; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOSIS;

EID: 0142094492     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0037-1963(03)00198-7     Document Type: Article

References (77)

1. Abboud M, Laver J, Blau CA: Granulocytosis causing sickle-cell crisis. Lancet 351:959, 1998
2. Ameyaw MM, Collie-Duguid ES, Powrie RH, et al: Thiopurine methyltransferase alleles in British and Ghanaian populations. Hum Mol Genet 8:367-370, 1999
3. Black AJ, McLeod HL, Capell HA, et al: Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine. Ann Intern Med 129:716-718, 1998
4. Botstein D, Risch N: Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet 33:228-237, 2003 (suppl)
5. Brookes AJ: Rethinking genetic strategies to study complex diseases. Trends Mol Med 7:512-516, 2001
6. Cargill M, Altshuler D, Ireland J, et al: Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 22:231-238, 1999
7. Carroll JE, McKie V, Kutlar A: Are sickle cell disease patients with stroke genetically predisposed to the event by inheriting a tendency to high tumor necrosis factor levels? Am J Hematol 58:250, 1998
8. Chanock S, Taylor JG: Using genetic variation to study immunomodulation. Curr Opin Pharmacol 2:463-469, 2002
9. Chanock SJ, Foster CB: SNPing away at innate immunity. J Clin Invest 104:369-370, 1999
10. Chanock S, Wacholder S: One gene and one outcome? No way. Trends Mol Med 8:266-269, 2002
11. Chanock S: Candidate genes and single nucleotide polymorphisms (SNPs) in the study of human disease. Dis Markers 17:89-98, 2001
12. Choi EH, Foster CB, Taylor JG, et al: Association between chronic disseminated candidiasis in adult acute leukemia and common IL4 promoter haplotypes. J Infect Dis 187:1153-1156, 2003
13. Choi EH, Lee HJ, Yoo T, et al: A common haplotype of interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children. J Infect Dis 186:1207-1211, 2002
14. a. Clayton D, McKeigue PM: Epidemiological methods for studying gene and environmental factors in complex diseases. Lancet 358:1356-1360, 2001
15. Collie-Duguid ES, Pritchard SC, Powrie RH, et al: The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics 9:37-42, 1999
16. Collins FS, Guyer MS, Charkravarti A: Variations on a theme: Cataloging human DNA sequence variation. Science 278:1580-1581, 1997
17. Collins A, Lonjou C, Morton NE: Genetic epidemiology of single-nucleotide polymorphisms. Proc Natl Acad Sci USA 96:15173-15177, 1999
18. Collins FS, Green ED, Guttmacher AE, et al: A vision for the future of genomics research. Nature 422:835-847, 2003
19. Collins FS: Shattuck lecture - Medical and societal consequences of the Human Genome Project. N Engl J Med 341:28-37, 1999
20. Daly MJ, Rioux JD, Schaffner SF, et al: High-resolution haplotype structure in the human genome. Nat Genet 29:229-232, 2001
21. Davies SM, Bhatia S, Ross JA, et al: Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia. Blood 100:67-71, 2002
22. Dervieux T, Blanco JG, Krynetski EY, et al: Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells. Cancer Res 61:5810-5816, 2001
23. Duan J, Wainwright MS, Comeron JM, et al: Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 12:205-216, 2003
24. Dumur CI, Dechsukhum C, Ware JL, et al: Genome-wide detection of LOH in prostate cancer using human SNP microarray technology. Genomics 81:260-269, 2003
25. Excoffier L, Slatkin M: Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol Biol Evol 12:921-927, 1995
26. Fallin D, Cohen A, Essioux L, et al: Genetic analysis of case/control data using estimated haplotype frequencies: Application to APOE locus variation and Alzheimer's disease. Genome Res 11:143-151, 2001
27. Foster CB, Lehrnbecher T, Mol F, et al: Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J Clin Invest 102:2146-2155, 1998
28. Gabolde M, Guilloud-Bataille M, Feingold J, et al: Association of variant alleles of mannose binding lectin with severity of pulmonary disease in cystic fibrosis: Cohort study. BMJ 319:1166-1167, 1999
29. Gabriel SB, Schaffner SF, Nguyen H, et al: The structure of haplotype blocks in the human genome. Science 296:2225-2229, 2002
30. Garred P, Pressler T, Lanng S, et al: Mannose-binding lectin (MBL) therapy in an MBL-deficient patient with severe cystic fibrosis lung disease. Pediatr Pulmonol 33:201-207, 2002
31. Garred P, Pressler T, Madsen HO, et al: Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest 104:431-437, 1999
32. Garred P, Voss A, Madsen HO, et al: Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients. Genes Immun 2:442-450, 2001
33. Glatt CE, DeYoung JA, Delgado S, et al: Screening a large reference sample to identify very low frequency sequence variants: Comparisons between two genes. Nat Genet 27:435-438, 2001
34. Halushka MK, Fan JB, Bentley K, et al: Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nat Genet 22:239-247, 1999
35. Hirschhorn JN, Lohmueller K, Byrne E, et al: A comprehensive review of genetic association studies. Genet Med 4:45-61, 2002
36. Hoal-Van Helden EG, Epstein J, Victor TC, et al: Mannose-binding protein B allele confers protection against tuberculous meningitis. Pediatr Res 45:459-464, 1999
37. Hoppe C, Klitz W, Noble J, et al: Distinct HLA associations by stroke subtype in children with sickle cell anemia. Blood 101:2865-2869, 2003
38. Hoppe C, Cheng S, Grow M, et al: A novel multilocus genotyping assay to identify genetic predictors of stroke in sickle cell anaemia. Br J Haematol 114:718-720, 2001
39. Hoque MO, Lee CC, Cairns P, et al: Genome-wide genetic characterization of bladder cancer: A comparison of high-density single-nucleotide polymorphism arrays and PCR-based microsatellite analysis. Cancer Res 63:2216-2222, 2003
40. Infante-Rivard C, Amre D, Sinnett D: GSTT1 and CYP2E1 polymorphisms and trihalomethanes in drinking water: Effect on childhood leukemia. Environ Health Perspect 110: 591-593, 2002
41. Innocenti F, Iyer L, Ratain MJ: Pharmacogenetics: A tool for individualizing antineoplastic therapy. Clin Pharmacokinet 39:315-325, 2000
42. Johnson GC, Esposito L, Barratt BJ, et al: Haplotype tagging for the identification of common disease genes. Nat Genet 29:233-237, 2001
43. Krajinovic M, Labuda D, Sinnett D: Glutathione S-transferase P1 genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukaemia. Pharmacogenetics 12:655-658, 2002
44. Krajinovic M, Sinnett H, Richer C, et al: Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia, Int J Cancer 97:230-236, 2002
45. Kruglyak L, Nickerson DA: Variation is the spice of life. Nat Genet 27:234-236, 2001
46. Kruglyak L: Prospects for whole-genome linkage disequilibrium mapping of common disease genes, Nat Genet 22:139-144, 1999
47. Lander ES, Linton LM, Birren B, et al: Initial sequencing and analysis of the human genome. Nature 409:860-921, 2001
48. Lane DA, Grant PJ: Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 95:1517-1532, 2000
49. Lindblad-Toh K, Tanenbaum DM, Daly MJ, et al: Loss-of-heterozygosity analysis of small-cell lung carcinomas using single-nucleotide polymorphism arrays. Nat Biotechnol 18:1001-1005, 2000
50. Lohmueller KE, Pearce CL, Pike M, et al: Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33:177-182, 2003
51. McLeod HL, Lin JS, Scott EP, et al: Thiopurine methyltransferase activity in American white subjects and black subjects. Clin Pharmacol Ther 55:15-20, 1994
52. McLeod HL, Evans WE: Pharmacogenomics: Unlocking the human genome for better drug therapy. Annu Rev Pharmacol Toxicol 41:101-121, 2001
53. McLeod HL, Pritchard SC, Githang'a J, et al: Ethnic differences in thiopurine methyltransferase pharmacogenetics: Evidence for allele specificity in Caucasian and Kenyan individuals. Pharmacogenetics 9:773-776, 1999
54. Mullighan CG, Heatley S, Doherty K, et al: Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood 99:3524-3529, 2002
55. Neth O, Hann I, Turner MW, et al: Deficiency of mannose-binding lectin and burden of infection in children with malignancy: A prospective study. Lancet 358:614-618, 2001
56. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al: Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 91:288-294, 1998
57. Orkin SH, Kazazian HH Jr, Antonarakis SE, et al: Linkage of beta-thalassaemia mutations and beta-globin gene polymorphisms with DNA polymorphisms in human beta-globin gene cluster. Nature 296:627-631, 1982
58. Peterslund NA, Koch C, Jensenius JC, et al: Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet 358:637-638, 2001
59. Pritchard JK: Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet 69:124-137, 2001
60. Rieder MJ, Taylor SL, Clark AG, et al: Sequence variation in the human angiotensin converting enzyme. Nat Genet 22:59-62, 1999
61. Risch N, Merikangas K: The future of genetic studies of complex human diseases. Science 273:1516-1517, 1996
62. Risch N: The genetic epidemiology of cancer: Interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol Biomarkers Prev 10:733-741, 2001
63. Risch NJ: Searching for genetic determinants in the new millennium. Nature 405:847-856, 2000
64. RosesAD: Genome-based pharmacogenetics and the pharmaceutical industry. Nat Rev Drug Discov 1:541-549, 2002
65. Rothman N, Wacholder S, Caporaso NE: The use of common genetic polymorphisms to enhance the epidemiologic study of environmental carcinogens. Biochim Biophys Acta 1471: C1-10, 2001
66. Schaid DJ, Rowland CM, Tines DE, et al: Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70:425-434, 2002
67. Seligsohn U, Lubetsky A: Genetic susceptibility to venous thrombosis. N Engl J Med 344:1222-1231, 2001
68. Stram D, Haiman C, Hirschhorn J, et al: Chosing haplotype-tagging SNP based on unphased genotype data using a preliminary sample of the unrelated subjects with an example from the multiethnic cohort study. Human Hered 55:27-36, 2003
69. Takeuchi S, Tsukasaki K, Bartram CR, et al: Long-term study of the clinical significance of loss of heterozygosity in childhood acute lymphoblastic leukemia. Leukemia 7:149-154, 2003
70. Taylor JG, Choi EH, Foster CB, et al: Using genetic variation to study human disease. Trends Mol Med 7:507-512, 2001
71. Taylor JG, Tang DC, Savage SA, et al: Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease. Blood 100:4303-4309, 2002
72. Taylor JG, Tang D, Foster CB, et al: Patterns of low-affinity immunoglobulin receptor polymorphisms in stroke and homozygous sickle cell disease. Am J Hematol 69:109-114, 2002
73. Venter JC, Adams MD, Myers EW, et al: The sequence of the human genome. Science 16:1304-1351, 2001
74. Wacholder S, Garcia-Closas M, Rothman N: Study of genes and environmental factors in complex diseases. Lancet 359:1155, 2002
75. Weinshilboum RM, Sladek SL: Mercaptopurine pharmacogenetics: Monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 32:651-662, 1980
76. Winkelstein JA, Marino MC, Johnston RB Jr, et al: Chronic granulomatous disease: Report on a national registry of 368 patients. Medicine (Baltimore) 79:155-169, 2000
77. Zhang S, Zhao H: Linkage disequilibrium mapping in populations of variable size using the decay of haplotype sharing and a stepwise-mutation model. Genet Epidemiol 19:S99-105, 2000 (suppl 1)